Management of urticaria and angioedema.
D000799:Angioedema / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D001241:Aspirin / Q000009:adverse effects; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency; D003165:Complement System Proteins; D003240:Connective Tissue Diseases / Q000150:complications; D005512:Food Hypersensitivity / Q000209:etiology; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E; D007239:Infections / Q000150:complications; D007705:Kinins / Q000378:metabolism; D009369:Neoplasms / Q000150:complications; D010406:Penicillins / Q000009:adverse effects; D011453:Prostaglandins / Q000378:metabolism; D013315:Stress, Psychological; D014581:Urticaria / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*
D003174:Complement C1 Inactivator Proteins; D007705:Kinins; D010406:Penicillins; D011453:Prostaglandins; D007073:Immunoglobulin E; D003165:Complement System Proteins; D001241:Aspirin